STAT+: Karuna Therapeutics replaces its CEO, suggesting takeover unlikely soon

Karuna Therapeutics said Tuesday that its CEO, Steve Paul, will be replaced by Bill Meury, a private equity investor and former pharmaceutical executive, suggesting a takeover is unlikely in the near future.

Paul will remain with the company as chief scientific officer and a member of its board. Christopher Coughlin, the company’s lead independent director, will take Paul’s role as chair of the board. Meury will take over as CEO on Jan. 3.

Continue to STAT+ to read the full story…

This post was originally published on this site

Leave a Reply

error: Content is protected !!
Open chat
WhatsApp Now